3D Medicines Overview
3D Medicines (1244.HK) has a PEG ratio of 63.59, above the Healthcare sector average of 0.46.
Get informed when a big investor buys or sells
+ Follow63.59
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for 1244.HK is 63.59. That is above the Healthcare sector average of 0.46. Investors often review this figure alongside 3D Medicines's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, 1244.HK currently prints 63.59 for PEG ratio, while the sector average sits near 0.46. That is roughly 13617.2% above the sector mean. Large gaps often invite a closer look at 3D Medicines's growth, margins, and balance sheet.
A PEG ratio of 63.59 for 3D Medicines is not 'good' or 'bad' on its own. Compare it with the peer average (0.46) and with 1244.HK's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting 1244.HK's PEG ratio (63.59), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack 3D Medicines's PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
